Your new experience awaits. Try the new design now and help us make it even better

BRIEF RESEARCH REPORT article

Front. Cell. Infect. Microbiol.

Sec. Veterinary and Zoonotic Infection

Volume 15 - 2025 | doi: 10.3389/fcimb.2025.1660446

This article is part of the Research TopicUnveiling Host-Pathogen Interactions: Insights into Animal Cellular Immunity and Novel Diagnostics - Volume IIView all 18 articles

Highly Efficient Gene Editing of Feline Herpesvirus 1 (FHV-1) Using CRISPR/Cas9 Combined with FACS

Provisionally accepted
Hai-Ming  WangHai-Ming Wang1Shi-Jia  XuShi-Jia Xu2Bing-Yan  CaiBing-Yan Cai1Wen-Ying  QiuWen-Ying Qiu3Hui  LuHui Lu1Yan-Dong  TangYan-Dong Tang2*
  • 1Jiangsu Agri-animal Husbandry Vocational College, Taizhou, China
  • 2Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China
  • 3College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, China

The final, formatted version of the article will be published soon.

Feline herpesvirus 1 (FHV-1) is a major causative agent of feline viral rhinotracheitis and ocular lesions. Due to its large DNA genome, the construction of recombinant FHV-1 viruses presents considerable challenges for conventional methodologies. In this study, we implemented an integrated strategy combining CRISPR/Cas9-mediated gene editing with fluorescence-activated cell sorting (FACS) to enable the rapid and efficient generation of recombinant FHV-1 viruses. Specifically, the thymidine kinase (tk) gene was disrupted by inserting a monomeric Cherry (mCherry) reporter gene, and the glycoprotein E (gE) gene was similarly interrupted through the incorporation of a green fluorescent protein (GFP) reporter. The CRISPR/Cas9 system enables precise, sitespecific genomic modifications, while FACS allows for effective enrichment and isolation of the desired recombinant viral populations. This combined approach significantly reduces the time required for recombinant virus generation from weeks to days, thereby offering substantial potential to expedite vaccine development and advance functional genomics research.

Keywords: Feline herpesvirus 1 (FHV-1), CRISPR/Cas9, Fluorescence-activated cell sorting (FACS), Homologous Recombination, gene knockout

Received: 06 Jul 2025; Accepted: 06 Aug 2025.

Copyright: © 2025 Wang, Xu, Cai, Qiu, Lu and Tang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Yan-Dong Tang, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.